CD274 and neoplasm: Fang Sun et al. reported a prodrug, bromodomain-containing protein 4 inhibitor (BRD4i) JQ1, that counteracts C-myc and PD-L1 expression of tumor cell post PDT stimulation (Figure 4) [72].